pocketful logo
Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

NSE: MAXHEALTH BSE: 543220

1025.45

(2.19)%

Wed, 04 Feb 2026, 04:08 pm

Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Unable to evaluate Max India's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
    • Unable to evaluate Max India's dividend against the top 25% market benchmark as the company has not reported any payouts.

    health

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • Max India's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
      • Debt is not well covered by operating cash flow (8.6%, less than 20% of total debt).
      • Debt is not covered by short term assets, assets are 0.4x debt.
      • Max India's long term commitments exceed its cash and other short term assets.
      • The level of debt compared to net worth has increased over the past 5 years (85.2% vs 103.8% today).
      • Max India is making a loss, therefore interest payments are not well covered by earnings.
      • Max India's level of debt (103.8%) compared to net worth is high (greater than 40%).
      • High level of physical assets or inventory.

      management

      thumbs up icon

      Pros

      • The tenure for the Max India management team is about average.
      thumbs up icon

      Cons

        misc

        thumbs up icon

        Pros

          thumbs up icon

          Cons

          • Max India is not covered by any analysts.
          • Max India's last earnings update was 399 days ago.

          past

          thumbs up icon

          Pros

            thumbs up icon

            Cons

            • Unable to compare Max India's 1-year earnings growth to the 5-year average as it is not currently profitable.
            • Max India does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
            • Max India used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
            • It is difficult to establish if Max India improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
            • It is difficult to establish if Max India has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
            • Unable to compare Max India's 1-year growth to the IN Healthcare industry average as it is not currently profitable.

            value

            thumbs up icon

            Pros

              thumbs up icon

              Cons

              • Max India is overvalued based on assets compared to the IN Healthcare industry average.
              • Max India is loss making, we can't compare its value to the IN Healthcare industry average.
              • Max India is loss making, we can't compare the value of its earnings to the India market.

              Open Your Free Demat Account Now!

              Step into a world of zero fees and limitless opportunities!

              pocketful logo

              2022-25 Pocketful. All rights reserved, Built with in India

              Version -5.76

              app image 1app image 2

              Explore

              Calculatorsfooter arrow down icon
              Popular Calculatorsfooter arrow down icon
              Group Stocksfooter arrow down icon

              Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800